Poliscio Analytics LLC
  • Daily Alerts
  • Insights
    • Our Insights Articles
    • Project 2025
  • FOIAengine
    • Log In
    • About FOIA Engine
    • Trial User Signup
    • User Support
    • How to Use
  • FOIA Services
  • About
    • About PoliScio
    • Leadership
    • Newsroom
  • Contact
Select Page
How Requesters Use FOIA to Asses Biopharma Risks

How Requesters Use FOIA to Asses Biopharma Risks

by Randy Miller | May 6, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market

FOIAengine: Assessments Include Operational, Clinical and Commercial Threats Freedom of Information Act requests to the Food and Drug Administration during March illustrated three of the primary uncertainties facing U.S. drug manufacturers and their investors: the...
1789 Capital Raises $861 Million for MAGA Investments

1789 Capital Raises $861 Million for MAGA Investments

by John A. Jenkins | Sep 3, 2025 | FOIA, Hedge Funds, News Media, Politics, SEC

FOIAengine: Wall Street Journal Seeking SEC Emails and Texts Involving the Trump-Affiliated Venture Capital Firm The Wall Street Journal is pressing the Securities and Exchange Commission for records involving Trump-affiliated 1789 Capital – a timely request after a...
How Requesters Use FOIA to Asses Biopharma Risks

Some Research Into Short-Seller Culper Research

by John A. Jenkins | Jul 17, 2025 | FDA, FOIA, Hedge Funds, Stock Market

FOIAengine:  How a Proxy Requester Masks Its Identity On April 14, 2021, online forums where retail investors and short sellers exchange research, rumors, and trading strategies were buzzing.     On Reddit and Twitter, meme stock traders were watching for the next big...
How Requesters Use FOIA to Asses Biopharma Risks

ExodusPoint Gains A Unique Advantage

by John A. Jenkins | Jul 9, 2025 | FDA, FOIA, Hedge Funds, Stock Market

FOIAengine: Decoding How a Hedge Fund Tracks FDA Requests ExodusPoint burst onto the hedge fund scene in 2018 with the largest launch in history — raising $8.5 billion out of the gate — powered by institutional backing, an elite Wall Street pedigree, and high-profile...
How Requesters Use FOIA to Asses Biopharma Risks

Questions About High-Flying Insulet Corp.

by Randy Miller | May 28, 2025 | FDA, FOIA, Hedge Funds, Medical Devices, Stock Market

FOIAengine: Multiple Hedge Funds Seeking Inspection Reports Leading medical device manufacturer Insulet Corporation’s stock price (NASDAQ: PODD) is on a roll. But that hasn’t stopped financial firms from monitoring the company’s Food and Drug Administration plant...
Hedge Fund Point72 Targets J&J Cancer Drug

Hedge Fund Point72 Targets J&J Cancer Drug

by Randy Miller | Apr 23, 2025 | FDA, FOIA, Hedge Funds, Pharmaceuticals

FOIAengine: Questions Seek Adverse Reports about  Carvykti According to a new PoliScio Analytics analysis of early 2025 Freedom of Information Act requests, investment firm Point72 has launched a significant FOIA-driven investigation into Johnson &...
« Older Entries
  • Terms of Service
  • Privacy Policy
  • Text-to-Speech
Copyright 2026 PoliScio Analytics LLC